Skip to content

To Evaluate the Efficacy of Chavyadi Saktuk in the Management of Sthaulya w.s.r to Obesity

An Open Single Arm Study To Evaluate the Efficacy Of Chavyadi Saktuk In The Management Of Sthaulya w.s.r To Obesity - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105367
Enrollment
60
Registered
2026-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs

Interventions

None listed

Sponsors

Radhika Nitin Somani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subject having age group 21 to 60 years irrespective of their sex, religion, marital status and socioeconomic class . 2. Patient having signs and symptoms of obesity mentioned in Ayurvedic classics like aayusho rhaso , javoparodh , kruchvyavayata ,daurbalya, Daurgandhya , Swedabadh , Kshudatimatra, pipasaatiyogshcheti. 3.Patient ready to give written informed consent. 4.Patient having BMI Of 25.0 To 29.9

Exclusion criteria

Exclusion criteria: 1.Patients below 21yrs and above 60yrs of age. 2. patients suffering from serious diseases like cardiovascular disease ,malignancy ,tuberculosis , Anaemia , Hepatitis , diabetes melliatus , cushing syndrome , Renal failure . 3.Lactating and pregnant women. 4.Patient not ready to give written informed consent. 5. Obesity and hyperlipidemia due to drugs e.g Anticonvulsant , Beta blockers , Corticosteroid .

Design outcomes

Primary

MeasureTime frame
Assessment will be done based on subjective criteria. Subjective criteria is Alasya,Kshudrashwas,swedadhikya,Daurbalya,Atikshudha, Daurgandhya will be assessed based on before and after treatment.Timepoint: 60 days

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Radhika Nitin Somani

Vidarbha Ayurved Mahavidyalaya, Amravati

vaishalivhww@gmail.com9420125432

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026